Current advances in the diagnosis and management of intracranial germ cell tumors.
Central nervous system (CNS) germ cell tumors (GCT) account for less than 5% of primary brain tumors in children and young adults, but they continue to attract much attention. Over the past decade, two advances have led to re-evaluation of what constitutes conventional therapy for CNS GCT. For pure germinomas, the challenge remains the determination of the optimal field and dose of irradiation and whether or not the use of chemotherapy can lead to a reduced dose or elimination of irradiation altogether without compromising disease control or survival. For non-germinomatous germ cell tumors, an improvement in the current dismal prognosis is imperative.
Balmaceda
Casilda
C
Neurological Institute, Columbia University College of Physicians & Surgeons, 710 W. 168th Street, New York, NY 10032, USA. cb116@columbia.edu
Finlay
Jonathan
J
D001932:Brain Neoplasms / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D009373:Neoplasms, Germ Cell and Embryonal / Q000175:diagnosis* / Q000628:therapy*